Mushroom toxicity: Difference between revisions
No edit summary |
|||
| Line 11: | Line 11: | ||
==Clinical Features== | ==Clinical Features== | ||
===Early-Onset | ===Early-Onset=== | ||
''Depends on the type of mushroom ingested'' | ''Depends on the type of mushroom ingested'' | ||
*GI | *GI | ||
| Line 27: | Line 27: | ||
**Flushing, tachycardia, diaphoresis, hypotension | **Flushing, tachycardia, diaphoresis, hypotension | ||
===Delayed-Onset | ===Delayed-Onset=== | ||
''Four Stages <ref>Brayer AF, Froula L. Mushroom poisoning. In: Tintinalli JE, Stapczynski J, Ma O, Yealy DM, Meckler GD, Cline DM, eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 8th ed. New York, NY: McGraw-Hill; 2016:(Ch) 219.</ref> <ref>Shih RD. Plants, mushrooms and herbal medications. In: Walls RM, Hockberger RS, Gausche-Hill M, eds. Rosen's Emergency Medicine: Concepts and Clinical Practice. 9th ed. Philadelphia, PA: Elsevier; 2018:(Ch) 164.</ref>'' | ''Four Stages <ref>Brayer AF, Froula L. Mushroom poisoning. In: Tintinalli JE, Stapczynski J, Ma O, Yealy DM, Meckler GD, Cline DM, eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 8th ed. New York, NY: McGraw-Hill; 2016:(Ch) 219.</ref> <ref>Shih RD. Plants, mushrooms and herbal medications. In: Walls RM, Hockberger RS, Gausche-Hill M, eds. Rosen's Emergency Medicine: Concepts and Clinical Practice. 9th ed. Philadelphia, PA: Elsevier; 2018:(Ch) 164.</ref>'' | ||
#Latent (symptom free, up to 24 hours) | #Latent (symptom free, up to 24 hours) | ||
| Line 38: | Line 38: | ||
==Evaluation== | ==Evaluation== | ||
===Early-Onset | ===Early-Onset=== | ||
*Comprises majority of mushroom-induced intoxications | *Comprises majority of mushroom-induced intoxications | ||
*Symptom onset 30-90 min with hallucinations, lasting 6-8 hrs<ref>Rolston-Cregler L et al. Hallucinogenic Mushroom Toxicity. Apr 08, 2015. http://emedicine.medscape.com/article/817848-overview.</ref>: | *Symptom onset 30-90 min with hallucinations, lasting 6-8 hrs<ref>Rolston-Cregler L et al. Hallucinogenic Mushroom Toxicity. Apr 08, 2015. http://emedicine.medscape.com/article/817848-overview.</ref>: | ||
| Line 44: | Line 44: | ||
**Psilocybin - euphoria, visual hallucinations, agitation, sympathomimetic Sxs | **Psilocybin - euphoria, visual hallucinations, agitation, sympathomimetic Sxs | ||
===Delayed-Onset | ===Delayed-Onset=== | ||
*Hypoglycemia is common cause of death, needs close monitoring | *Hypoglycemia is common cause of death, needs close monitoring | ||
==Management== | ==Management== | ||
===Early-Onset | ===Early-Onset=== | ||
*GI predominant symptoms: | *GI predominant symptoms: | ||
**Activated charcoal 0.5-1gm/kg | **Activated charcoal 0.5-1gm/kg | ||
| Line 59: | Line 59: | ||
**Consider atropine for severe symptoms; 0.5-1mg IV for adults; 0.01mg/kg IV for peds | **Consider atropine for severe symptoms; 0.5-1mg IV for adults; 0.01mg/kg IV for peds | ||
===Delayed-Onset | ===Delayed-Onset=== | ||
Consider [[Amanita mushrooms|Amatoxin-specific treatments]]: | Consider [[Amanita mushrooms|Amatoxin-specific treatments]]: | ||
*[[Activated charcoal]] | *[[Activated charcoal]] | ||
| Line 70: | Line 70: | ||
==Disposition== | ==Disposition== | ||
===Early-Onset | ===Early-Onset=== | ||
*Discharge once symptoms have subsided | *Discharge once symptoms have subsided | ||
===Delayed-Onset | ===Delayed-Onset=== | ||
*Amanita species causes 95% of deaths | *Amanita species causes 95% of deaths | ||
**Toxin inhibits formation of mRNA and is heat stable | **Toxin inhibits formation of mRNA and is heat stable | ||
Revision as of 17:39, 13 September 2018
Background
Clinically broken into two main categories:
- Early-Onset Poisoning (toxicity begins within 2hr of ingestion)
- Clinical course is usually benign
- Late-Onset Poisoning (toxicity begins 6hr after ingestion)
- Clinical course is often serious/ possibly fatal
Mushroom toxicity by Type
| Mushroom | Toxin | Pathologic Effect |
| Amanita | Amatoxin | Hepatotoxicity |
| Coprine | Disulfiram-like | |
| Crotinarius | Orellanine | Delayed renal failure |
| Gyromitra | Gyromitrin | Seizures |
| Ibotenic Acid | Anticholinergic | |
| Muscarine | Cholinergic | |
| Orellanin | Nephrotoxicity | |
| Psilocybin | Hallucinations |
Mushroom Identification
Clinical Features
Early-Onset
Depends on the type of mushroom ingested
- GI
- Nausea/vomiting/diarrhea
- Resolves within 24hr
- CNS
- Euphoria, hallucinations
- Lasts 4-6hr
- Muscarinic
- SLUDGE symptoms
- Diaphoresis, muscle fasciculations, miosis, bradycardia, bronchorrhea
- Resolves in 4-12hr
- Disulfiram-like effect
- Usually when drinking alcohol
- Flushing, tachycardia, diaphoresis, hypotension
Delayed-Onset
- Latent (symptom free, up to 24 hours)
- Symptomatic (GI distress)
- Convalescent (feel better, but LFT's increasing)
- Fulminant (day 2-4)
Differential Diagnosis
Causes of acute hepatitis
- Acetaminophen toxicity (most common cause of acute liver failure in the US[3])
- Viral hepatitis
- Toxoplasmosis
- Acute alcoholic hepatitis
- Toxins
- Ischemic hepatitis
- Autoimmune hepatitis
- Wilson's disease
Evaluation
Early-Onset
- Comprises majority of mushroom-induced intoxications
- Symptom onset 30-90 min with hallucinations, lasting 6-8 hrs[4]:
- Isoxazoles (ibotenic acid and muscimol) - dsyarthria, ataxia, muscle cramps
- Psilocybin - euphoria, visual hallucinations, agitation, sympathomimetic Sxs
Delayed-Onset
- Hypoglycemia is common cause of death, needs close monitoring
Management
Early-Onset
- GI predominant symptoms:
- Activated charcoal 0.5-1gm/kg
- Do not give antidiarrheal meds
- CNS predominant symptoms:
- Place in dark, quiet room
- Benzos may be given to patients who are agitated
- Consider pyridoxine for refractory seizures, especially if suspecting gyromitra[5]
- Muscarinic predominant symptoms:
- Consider atropine for severe symptoms; 0.5-1mg IV for adults; 0.01mg/kg IV for peds
Delayed-Onset
Consider Amatoxin-specific treatments:
- Activated charcoal
- N-Acetylcysteine (NAC): 150 mg/kg over one hour, 50 mg/kg over 4 hours, 100 mg/kg over 16 hours
- Call poison control, consider:
- Penicillin G
- Silibinin dihemisuccinate
- Cimetidine
- Vitamin C
Disposition
Early-Onset
- Discharge once symptoms have subsided
Delayed-Onset
- Amanita species causes 95% of deaths
- Toxin inhibits formation of mRNA and is heat stable
- Most frequent species: A. phalloides, bisporigera, magnivelaris, ocreata, verna, virosa[6]
References
- ↑ Brayer AF, Froula L. Mushroom poisoning. In: Tintinalli JE, Stapczynski J, Ma O, Yealy DM, Meckler GD, Cline DM, eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 8th ed. New York, NY: McGraw-Hill; 2016:(Ch) 219.
- ↑ Shih RD. Plants, mushrooms and herbal medications. In: Walls RM, Hockberger RS, Gausche-Hill M, eds. Rosen's Emergency Medicine: Concepts and Clinical Practice. 9th ed. Philadelphia, PA: Elsevier; 2018:(Ch) 164.
- ↑ Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17; 137(12): 947-54.
- ↑ Rolston-Cregler L et al. Hallucinogenic Mushroom Toxicity. Apr 08, 2015. http://emedicine.medscape.com/article/817848-overview.
- ↑ Berger KJ, Guss DA. Mycotoxins revisited: Part II. J Emerg Med. 2005;28(2):175.
- ↑ Enjalbert F et al. Treatment of Amatoxin Poisoning: 20 year retrospective analysis. J tox Clin Tox 2002 40(6):715-767.
